While many efforts are being made to help the research community, one decision by the Canadian Institutes for Health Research (CIHR) has been widely condemned: the suspension of the Spring 2020 Project Grant competition.
Organization: University Hospital Network
Toronto Innovation Acceleration Partners joins with biotech giant Amgen to fund disruptive technologies
The commercialization organization formerly known as MaRS Innovation announced a new collaboration with the biotechnology company Amgen, to identify and jointly fund disruptive technologies derived from discovery research conducted in Toronto.